The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
Transforming growth factor-β in cancer and metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“validation, a set of genes has been identified that marks and mediates breast cancer metastasis to the lung [107].”
BackgroundTGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967 · cited 1×
“Two to three weeks after birth, the TGF-β1 knockout mouse develops a wasting syndrome that is characterized by weight loss and multifocal infiltration of inflammatory cells in many organs, including the lungs, heart, and salivary glands, and progresses until the vital functions of the heart and lungs are compromised […”
BackgroundEpithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401 · cited 1×
“squamous cell carcinoma of the forestomach, both of which are associated with an increased abundance of stromal cells [16].”
BackgroundCancer epidemiology biomarkers & prevention
Press, H. (1991) · Cited by 1,398
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
Marie, J. C., Letterio, J. J., Gavin, M., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042276 · Cited by 985
Moustakas, A., & Heldin, C.-H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02554 · Cited by 958
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Järvinen, H. J., Sistonen, P., Tomlinson, I. P. M., Houlston, R. S., Bevan, S., Mitros, F. A., et al. (1998) · Science · doi:10.1126/science.280.5366.1086 · Cited by 907
Yang, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., & Wrana, J. L. (2005) · Science · doi:10.1126/science.1105718 · Cited by 881
Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor
Tucker, R. F., Shipley, G. D., Moses, H. L., & Holley, R. W. (1984) · Science · doi:10.1126/science.6093254 · Cited by 768
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells
Barrios-Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., Shinjo, F., Liu, Y., Dembowy, J., Taylor, I. W., et al. (2005) · Science · doi:10.1126/science.1105776 · Cited by 725
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses
Yu, L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf366 · Cited by 721
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689
Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction
Lebrin, F., Goumans, M., Jonker, L., Carvalho, R. L., Valdimarsdottir, G., Thorikay, M., Mummery, C., Arthur, H. M., & Dijke, P. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600386 · Cited by 652
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
Oft, M., Heider, K.-H., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 623
Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.-H., & Moustakas, A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0658 · Cited by 610
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
Foti, M. E., Mennite, M. A., Pusztay, H. M., Michael, M., Barry, A., Musumeci, L. P., Tang, D., Pickels, M. A., Griffith, T. A., Barbacid, M., et al. (1992) · Cited by 562
Development of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Activation of the Erk Pathway Is Required for TGF-β1-Induced EMT In Vitro
Xie, L., Law, B. K., Chytil, A. M., Brown, K. A., Aakre, M. E., & Moses, H. L. (2004) · Neoplasia · doi:10.1593/neo.04241 · Cited by 523
Datto, M. B., Frederick, J. P., Pan, L., Borton, A. J., Zhuang, Y., & Wang, X.-F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2495 · Cited by 473
Yang, E. Y., & Moses, H. L. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.731 · Cited by 464
Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., & Massagué, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932636100 · Cited by 429
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415
DaCosta Byfield, S., Major, C., Laping, N. J., & Roberts, A. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.744 · Cited by 414
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
Torre-Amione, G., Beauchamp, R. D., Koeppen, H., Park, B. H., Schreiber, H., Moses, H. L., & Rowley, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1486 · Cited by 403
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β
Feng, X.-H., Lin, X., & Derynck, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5178 · Cited by 397
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., & Wakefield, L. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318899 · Cited by 393
Welch, D. R., Fabra, A., & Nakajima, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7678 · Cited by 392
Pardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., & Moustakas, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909467199 · Cited by 392
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J., Neumann, A., Brattain, M. G., Chang, J., Kim, S., et al. (1999) · PubMed · Cited by 391
Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
Chen, R.-H., Ebner, R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388126 · Cited by 384
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Hahm, K.-B., Cho, K., Lee, C., Im, Y.-H., Chang, J., Choi, S.-G., Sorensen, P. H. B., Thiele, C. J., & Kim, S.-J. (1999) · Nature Genetics · doi:10.1038/13854 · Cited by 348
Gorsch, S. M., Memoli, V. A., Stukel, T. A., Gold, L. I., & Arrick, B. A. (1992) · PubMed · Cited by 343
Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22044 · Cited by 337
Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., & Sobol, R. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2909 · Cited by 334
Glick, A. B., Flanders, K. C., Danielpour, D., Yuspa, S. H., & Sporn, M. B. (1989) · Cell Regulation · doi:10.1091/mbc.1.1.87 · Cited by 330
Sun, L., Wu, G., Willson, J. K., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L. E., Wang, X. F., & Brattain, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47215-8 · Cited by 319
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998) · Nature Medicine · doi:10.1038/nm0798-802 · Cited by 314
Self-citationEyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310
Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010493y · Cited by 308
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Pierce, D. F., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4254 · Cited by 291
Goggins, M., Shekher, M. C., Turnacioglu, K. K., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1998) · PubMed · Cited by 288
Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation
Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J. B., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64926-7 · Cited by 285
The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., & Su, M. S. S. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90194-0 · Cited by 274
Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β
Wick, W., Platten, M., & Weller, M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012209518843 · Cited by 271
Cheng, N., Bhowmick, N. A., Chytil, A., Gorksa, A. E., Brown, K. A., Muraoka, R., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 267
Homozygous deletion map at 18q21.1 in pancreatic cancer.
Hahn, S. A., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Schutte, M. E. M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H., et al. (1996) · PubMed · Cited by 265
Yoo, J., Ghiassi, M., Jirmanova, L., Balliet, A. G., Hoffman, B., Fornace, A. J., Liebermann, D. A., Böttinger, E. P., & Roberts, A. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307869200 · Cited by 261
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif
Larisch, S., Yi, Y., Lotan, R., Kerner, H., Eimerl, S., Tony Parks, W., Gottfried, Y., Birkey Reffey, S., de Caestecker, M. P., Danielpour, D., et al. (2000) · Nature Cell Biology · doi:10.1038/35046566 · Cited by 259
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Kleeff, J., Ishiwata, T., Maruyama, H., Friess, H., Truong, P., Büchler, M. W., Falb, D., & Korc, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202909 · Cited by 258
Scandura, J. M., Boccuni, P., Massagué, J., & Nimer, S. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406771101 · Cited by 254
Dalal, B. I., Keown, P. A., & Greenberg, A. H. (1993) · PubMed · Cited by 252
Forrester, E., Chytil, A., Bierie, B., Aakre, M., Gorska, A. E., Sharif-Afshar, A.-R., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 249
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer.
Bubb, V., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Rg, M., White, S., Bird, C. C., & Wyllie, A. H. (1996) · PubMed · Cited by 246
Maytin, E. V., Ubeda, M., Lin, J. C., & Habener, J. F. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5248 · Cited by 244
c-myc Is a Downstream Target of the Smad Pathway
Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K., & Kato, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104170200 · Cited by 244
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., & Takahashi, T. (1996) · PubMed · Cited by 241
Lüttges, J., Galehdari, H., Bröcker, V., Schwarte-Waldhoff, I., Henne-Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241
Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice
Xu, X., Brodie, S. G., Yang, X., Im, Y.-H., Parks, W. T., Chen, L., Zhou, Y.-X., Weinstein, M., Kim, S.-J., & Deng, C.-X. (2000) · Oncogene · doi:10.1038/sj.onc.1203504 · Cited by 239
Kamaraju, A. K., & Roberts, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m403960200 · Cited by 227
Edlund, S., Bu, S., Schuster, N., Aspenström, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H., & Landström, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0037 · Cited by 226
Betticher, D., Heighway, J., Hasleton, P., Altermatt, H., Ryder, W., Cerny, T., & Thatcher, N. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.52 · Cited by 219
Xie, W. Q., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., Haffty, B. G., & Reiß, M. (2002) · PubMed · Cited by 217
Tuxhorn, J. A., McAlhany, S. J., Yang, F., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 216
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
Takaku, K., Miyoshi, H., Matsunaga, A., Oshima, M., Sasaki, N., & Taketo, M. M. (1999) · PubMed · Cited by 198
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
Amelioration of Radiation-induced Fibrosis
Xavier, S., Piek, E., Fujii, M., Javelaud, D., Mauviel, A., Flanders, K. C., Samuni, A. M., Felici, A., Reiss, M., Yarkoni, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309798200 · Cited by 191
Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L., & Arteaga, C. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8691-8703.2003 · Cited by 191
Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis
Kim, S.-J., Im, Y.-H., Markowitz, S. D., & Bang, Y.-J. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00039-8 · Cited by 188
Friedman, E. D., Gold, L. I., Klimstra, D., Zeng, Z., Winawer, S. J., & Cohen, A. M. (1995) · PubMed · Cited by 182
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta
Takekawa, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf643 · Cited by 175
Flanders, K. C., Major, C. D., Arabshahi, A., Aburime, E. E., Okada, M. H., Fujii, M., Blalock, T. D., Schultz, G. S., Sowers, A., Anzano, M. A., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63582-1 · Cited by 167
Seon, B. K., Matsuno, F., Haruta, Y., Kondo, M., & Barcos, M. P. (1997) · PubMed · Cited by 166
Singh, J., Chuaqui, C. E., Boriack-Sjodin, P. A., Lee, W.-C., Pontz, T., Corbley, M. J., Cheung, H.-K., Arduini, R. M., Mead, J. N., Newman, M. N., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.028 · Cited by 166
Loss of Smad3 in Acute T-Cell Lymphoblastic Leukemia
Wolfraim, L. A., Fernandez, T. M., Mamura, M., Fuller, W. L., Kumar, R., Cole, D. E., Byfield, S., Felici, A., Flanders, K. C., Walz, T. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031197 · Cited by 163
TGF-β singaling and cancer: structural and functional consequences of mutations in Smads
Hata, A., Massagué, J., & Shi, Y. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01247-7 · Cited by 161
Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A., & Arteaga, C. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2111 · Cited by 159
Sirard, C., Kim, S., Mirtsos, C., Tadich, P., Hoodless, P. A., Itié, A., Maxson, R., Wrana, J. L., & Mak, T. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2063 · Cited by 159
Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., & Derynck, R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.3.715 · Cited by 154
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma.Preprint
Glick, A. B., Lee, M., Darwiche, N., Kulkarni, A. B., Karlsson, S., & Yuspa, S. H. (1994) · Genes & Development · doi:10.1101/gad.8.20.2429 · Cited by 153
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150
A role for Id in the regulation of TGF-β-induced epithelial–mesenchymal transdifferentiation
Kondo, M., Cubillo, E., Tobiume, K., Shirakihara, T., Fukuda, N., Suzuki, H. I., Shimizu, K., Takehara, K., Cano, A., Saitoh, M., et al. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401467 · Cited by 149
Reiß, M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00251-8 · Cited by 146
Ueki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T., & Higashino, K. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90201-l · Cited by 142
Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shimizu, K., Aburatani, H., Mishima, H. K., Imamura, T., Miyazono, K., et al. (2003) · PubMed · Cited by 142
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay, A. M., López‐Casillas, F., Malik, S. N., Montiel-Hernández, J. L., Mendoza, V., Yang, J., & Sun, L. (2002) · PubMed · Cited by 140
Arteaga, C. L., Dugger, T. C., Moses, H. L., Hurd, S. D., & Pietenpol, J. A. (1993) · PubMed · Cited by 139
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakravarty, S., Dugar, S., & Reiss, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0018 · Cited by 138
Kang, S. H., Bang, Y., Im, Y., Yang, H.-K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., & Kim, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203146 · Cited by 136
Lonardo, F., Rusch, V. W., Langenfeld, J. E., Dmitrovsky, E., & Klimstra, D. S. (1999) · PubMed · Cited by 135
Rich, J. N., Zhang, M., Datto, M., Bigner, D. D., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35053 · Cited by 135
Xie, L., Law, B. K., Aakre, M. E., Edgerton, M. E., Shyr, Y., Bhowmick, N. A., & Moses, H. L. (2003) · Breast Cancer Research · doi:10.1186/bcr640 · Cited by 134
Ständer, M., Naumann, U., Dumitrescu, L., Heneka, M. T., Löschmann, P.-A., Gulbins, E., DICHGANS, J., & Weller, M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300709 · Cited by 132
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
Han, S., Kim, H.-T., Seong, D. H., Kim, Y. S., Park, Y., Bang, Y., Yang, H., & Kim, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207259 · Cited by 131
Smad pathway‐specific transcriptional regulation of the cell cycle inhibitor p21WAF1/Cip1
Pardali, K., Kowanetz, M., Heldin, C., & Moustakas, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20304 · Cited by 130
Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial Hyperplasia
Gobbi, H., Dupont, W. D., Simpson, J. F., Plummer, W. D., Schuyler, P. A., Olson, S. J., Arteaga, C. L., & Page, D. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2096 · Cited by 130
Is Smad3 a Major Player in Signal Transduction Pathways Leading to Fibrogenesis?
Roberts, A. B., Piek, E., Böttinger, E. P., Ashcroft, G. S., Mitchell, J. B., & Flanders, K. C. (2001) · CHEST Journal · doi:10.1016/s0012-3692(15)38703-1 · Cited by 128
Gorska, A. E., Jensen, R. A., Shyr, Y., Aakre, M. E., Bhowmick, N. A., & Moses, H. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63510-9 · Cited by 128
Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E., & Lodish, H. F. (1999) · Blood · doi:10.1182/blood.v94.8.2854.420k07_2854_2861 · Cited by 127
Pece-Barbara, N., Vera, S., Kathirkamathamby, K., Liebner, S., Guglielmo, G. M. D., Dejana, E., Wrana, J. L., & Letarte, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503471200 · Cited by 124
Xie, W. Q., Rimm, D. L., Lin, Y., Shih, W. J., & Reiß, M. (2003) · The Cancer Journal · doi:10.1097/00130404-200307000-00013 · Cited by 121
Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
Weeks, B. H., He, W., Olson, K. L., & Wang, X. J. (2001) · PubMed · Cited by 120
Wang, J., Han, W., Zborowska, E., Liang, J., Wang, X., Willson, J. K. V., Sun, L., & Brattain, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17366 · Cited by 120
Amendt, C., Schirmacher, P., Weber, H., & Blessing, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202161 · Cited by 119
He, J., Tegen, S. B., Krawitz, A. R., Martin, G., & Luo, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304016200 · Cited by 119
Lin, A. H., Luo, J., Mondshein, L. H., ten Dijke, P., Vivien, D., Contag, C. H., & Wyss‐Coray, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.547 · Cited by 116
Arteaga, C. L., Coffey, R. J., Dugger, T. C., McCutchen, C. M., Moses, H. L., & Lyons, R. M. (1990) · PubMed · Cited by 116
Stearns, M. E., Garcia, F. U., Fudge, K., Rhim, J. S., & Wang, M. (1999) · PubMed · Cited by 116
Ewan, K., Oketch‐Rabah, H. A., Ravani, S. A., Shyamala, G., Moses, H. L., & Barcellos‐Hoff, M. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62985-9 · Cited by 115
Bandyopadhyay, A. M., Zhu, Y., Cibull, M. L., Bao, L., Chen, C., & Sun, L. (1999) · PubMed · Cited by 115
Maitra, A., Molberg, K. H., Albores‐Saavedra, J., & Lindberg, G. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64625-1 · Cited by 112
Radisky, D. C., & Bissell, M. J. (2004) · Science · doi:10.1126/science.1094412 · Cited by 111
Wolfraim, L. A., Walz, T. M., James, Z., Fernandez, T., & Letterio, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3093 · Cited by 105
Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen, T., Triplett, J., Dehner, B., Hurst, B. M., Colligan, B. M., Pemberton, J. O., Graff, J. R., & Carter, J. H. (2001) · PubMed · Cited by 101
Marzo, A. L., Fitzpatrick, D. R., Robinson, B. W. S., & Scott, B. (1997) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 100
Chung, Y., Song, J., Lee, J. Y., Jung, Y. T., Seo, E., Choi, S. W., & Rhyu, M. (1996) · PubMed · Cited by 100
Peng, S.-B., Yan, L., Xia, X., Watkins, S. A., Brooks, H. B., Beight, D. W., Herron, D. K., Jones, M. L., Lampe, J. W., McMillen, W. T., et al. (2005) · Biochemistry · doi:10.1021/bi048851x · Cited by 100
Picon, A. I., Gold, L. I., Wang, J., Cohen, A. M., & Friedman, E. D. (1998) · PubMed · Cited by 100
The Loss of TGF-β Signaling Promotes Prostate Cancer Metastasis
Tu, W. H., Thomas, T. Z., Masumori, N., Bhowmick, N. A., Gorska, A. E., Shyr, Y., Kasper, S., Case, T., Roberts, R. L., Shappell, S. B., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80058-1 · Cited by 99
Law, B. K., Chytil, A., Dumont, N., Hamilton, E. G., Waltner-Law, M. E., Aakre, M. E., Covington, C. D., & Moses, H. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8184-8198.2002 · Cited by 99
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
Vijayachandra, K., Lee, J., & Glick, A. B. (2003) · PubMed · Cited by 96
Lu, S., Zhang, W. C., Akiyama, Y., Nomizu, T., & Yuasa, Y. (1996) · PubMed · Cited by 95
Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage
Barcellos‐Hoff, M. H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.08.010 · Cited by 95
Rowland‐Goldsmith, M., Maruyama, H., Kusama, T., Ralli, S., & Korc, M. (2001) · PubMed · Cited by 93
Kim, K.-Y., Kim, B.-C., Xu, Z., & Kim, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313947200 · Cited by 93
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
Platten, M., Wild‐Bode, C., Wick, W., Leitlein, J., DICHGANS, J., & Weller, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1289 · Cited by 91
Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (2000) · PubMed · Cited by 91
Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4
Morén, A., Itoh, S., Moustakas, A., ten Dijke, P., & Heldin, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203798 · Cited by 90
Tian, F., Byfield, S. D., Parks, W. T., Stuelten, C. H., Nemani, D., Zhang, Y. E., & Roberts, A. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0030 · Cited by 90
Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
Suh, N., Roberts, A. B., Reffey, S. B., Miyazono, K., Itoh, S., ten Dijke, P., Heiß, E. H., Place, A. E., Risingsong, R., Williams, C. R., et al. (2003) · PubMed · Cited by 90
Bandyopadhyay, A. M., Zhu, Y., Malik, S. N., Kreisberg, J. I., Brattain, M. G., Sprague, E. A., Luo, J., López‐Casillas, F., & Sun, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205439 · Cited by 87
Tang, B., de Castro, K. J. D., Barnes, H. E., Parks, W. T., Stewart, L. V., Böttinger, E. P., Danielpour, D., & Wakefield, L. M. (1999) · PubMed · Cited by 84
Jachimczak, P., Hessdörfer, B., Fabel, K., Wismeth, C., Brysch, W., Schlingensiepen, K., Bauer, A., Blesch, A., & Bogdahn, U. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960126)65:3<332::aid-ijc10>3.0.co;2-c · Cited by 82
Microsatellite instability and mutated type II transforming growth factor-β receptor gene in gliomas
Izumoto, S., Arita, N., Ohnishi, T., Hiraga, S., Taki, T., Tomita, N., Ohue, M., & Hayakawa, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04583-1 · Cited by 81
Chen, W., Lenschow, W., Tiede, K., Fischer, J. W., Kalthoff, H., & Ungefroren, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203709200 · Cited by 79
Go, C., Li, P., & Wang, X. (1999) · PubMed · Cited by 79
Proliferation and differentiation of prostatic stromal cells
Niu, Y., Xu, Y., Zhang, J., Bai, J., Yang, H., & Ma, T. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.00103.x · Cited by 78
Bandyopadhyay, A. M., Wang, L., López‐Casillas, F., Mendoza, V., Yeh, I., & Sun, L. (2004) · The Prostate · doi:10.1002/pros.20166 · Cited by 78
Biglari, A., Bataille, D., Naumann, U., Weller, M., Zirger, J. M., Castro, M. G., & Lowenstein, P. R. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700783 · Cited by 77
Albright, C. D., Salganik, R. I., Craciunescu, C. N., Mar, M.-H. H., & Zeisel, S. H. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10498 · Cited by 77
Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells
Lei, X., Bandyopadhyay, A. M., Le, T., & Sun, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205966 · Cited by 77
Iglesias, M., Frontelo, P., Gamallo, C., & Quintanilla, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203764 · Cited by 76
Okamoto, A., Jiang, W. B., Kim, S. J., Spillare, E. A., Stoner, G. D., Weinstein, I. B., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11576 · Cited by 76
Parekh, T. V., Gama, P., Wen, X., Demopoulos, R. I., Munger, J. S., Carcangiu, M. L., Reiß, M., & Gold, L. I. (2002) · PubMed · Cited by 76
Wu, S. P., Sun, L., Willson, J. K. V., Humphrey, L. E., Kerbel, R. S., & Brattain, M. G. (1993) · PubMed · Cited by 75
Chen, T., Wu, Y., Wells, R. G., Rimm, D. L., McNiff, J. M., Leffell, D. J., & Reiß, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1381 · Cited by 74
Transforming growth factor β and cancer
Nørgaard, P. H., Hougaard, S., Poulsen, H. S., & Spang‐Thomsen, M. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90038-1 · Cited by 73
Schlingensiepen, R., Goldbrunner, M., Szyrach, M., Stauder, G., Jachimczak, P., Bogdahn, U., Schulmeyer, F. J., Hau, P., & Schlingensiepen, K. (2005) · Oligonucleotides · doi:10.1089/oli.2005.15.94 · Cited by 69
Liu, X., Lee, J., Cooley, M. A., Bhogte, E., Hartley, S., & Glick, A. B. (2003) · PubMed · Cited by 67
Xie, W. Q., Bharathy, S., Kim, D. S., Haffty, B. G., Rimm, D. L., & Reiß, M. (2003) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000003108748612 · Cited by 65
Goto, D., Yagi, K., Inoue, H., Iwamoto, I., Kawabata, M., Miyazono, K., & Kato, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00658-9 · Cited by 61
Signaling and Endocytosis: A Team Effort for Cell Migration
Roy, C. L., & Wrana, J. L. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.07.007 · Cited by 60
Wojtowicz‐Praga, S., Verma, U. M., Wakefield, L. M., López-Jamar, J. M. E., Hartmann, D., & Mazumder, A. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199605000-00001 · Cited by 60
Vincent-Hubert, F., Hagiwara, K., Yang, K., Stoner, G. D., Demetrick, D. J., & Bennett, W. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0934 · Cited by 57
Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42
Edlund, S., Landström, M., Heldin, C., & Aspenström, P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01036 · Cited by 57
Cui, Q., Lim, S. K., Zhao, B. M., & Hoffmann, F. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208556 · Cited by 56
Kawate, S., Takenoshita, S., Ohwada, S., Mogi, A., Fukusato, T., Makita, F., Kuwano, H., & Morishita, Y. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.1.127 · Cited by 56
Park, J. A., Wang, E., Kurt, R. A., Schluter, S. F., Hersh, E. M., & Akporiaye, E. T. (1997) · PubMed · Cited by 56
Li, J., Kleeff, J. H., Kayed, H., Felix, K., Penzel, R., Büchler, M. W., Korc, M., & Frieß, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.063 · Cited by 54
Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF‐β1
Gerdes, M. J., Larsen, M., Dang, T. D., Ressler, S. J., Tuxhorn, J. A., & Rowley, D. R. (2003) · The Prostate · doi:10.1002/pros.10327 · Cited by 53
Yakymovych, I., Engström, U., Grimsby, S., Heldin, C., & Souchelnytskyi, S. (2002) · Biochemistry · doi:10.1021/bi025936u · Cited by 51
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer
Erickson, A., & Barcellos‐Hoff, M. H. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.1.71 · Cited by 49
Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion
Prunier, C., Mazars, A., Noë, V., Bruyneel, E. A., Mareel, M. M. K., Gespach, C. P., & Atfi, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22919 · Cited by 46
Adhesion and Rac1-dependent Regulation of Biglycan Gene Expression by Transforming Growth Factor-β
Groth, S., Schulze, M., Kalthoff, H., Fändrich, F., & Ungefroren, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504249200 · Cited by 46
Amoroso, S., Huang, N., Roberts, A. B., Potter, M., & Letterio, J. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.189 · Cited by 46
Kim, H., Kim, B., Letterio, J. J., & Leonard, W. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505833200 · Cited by 45
Abe, T., Ouyang, H. W., Migita, T., Kato, Y., Kimura, M., Shiiba, K., Sunamura, M., Matsuno, S., & Horii, A. (1996) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(96)92824-3 · Cited by 43
Arnold, N. B., & Korc, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500583200 · Cited by 39
Mechanism for Mutational Inactivation of the Tumor Suppressor Smad2
Prunier, C., Ferrand, N., Frottier, B., Pessah, M., & Atfi, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3302-3313.2001 · Cited by 37
Zhou, W. J., Park, I. I., Pins, M., Kozlowski, J. M., Jovanovic, B., Zhang, J., Lee, C., & Ilio, K. Y. (2003) · Endocrinology · doi:10.1210/en.2003-0554 · Cited by 36
Turco, A., Coppa, A., Aloe, S., Baccheschi, G., Morrone, S., Zupi, G., & Colletta, G. (1999) · International Journal of Cancer · Cited by 33
Pfeil, A. V., Hakenjos, L., Herskind, C., Dittmann, K., Weller, M., & Rodemann, H. P. (2002) · International Journal of Radiation Biology · doi:10.1080/095530002753676200 · Cited by 31
Fafeur, V., O'Hara, B., & Böhlen, P. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.2.135 · Cited by 30
Takanami, I., Tanaka, F., Hashizume, T., & Kodaira, S. (1997) · Journal of Surgical Oncology · Cited by 26
Development and possible clinical use of antagonists for PDGF and TGF-β
Heldin, C. (2004) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-083 · Cited by 26
The immunoregulatory roles of transforming growth factor beta.
Sosroseno, W., & Herminajeng, E. (1995) · PubMed · Cited by 26
Sabourin, C. L. K., Wang, Q.-S., Ralston, S. L., Evans, J. V., Coate, J., Herzog, C. R., Jones, S. L., Weghorst, C. M., Kelloff, G. J., Lubet, R. A., et al. (1998) · Experimental Lung Research · doi:10.3109/01902149809087383 · Cited by 24
Wu, Y., Vellucci, V. F., & Reiss, M. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747639 · Cited by 24
Cited by
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben-Porath, I., Onder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 848
Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018892108 · Cited by 733
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., & de Gramont, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 611
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., & Sahai, E. (2009) · Nature Cell Biology · doi:10.1038/ncb1973 · Cited by 601
Metadata
- Authors
- Jakowlew, S. B.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2006-09-02
- Volume
- 25
- Issue
- 3
- Pages
- 435-457
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1977657840
- Cited by
- 517
- References
- 204
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.